−0.51USD
−21.72 MUSD
159.01 MUSD
40.59 M
About Axogen, Inc.
Sector
Industry
CEO
Karen L. Zaderej
Website
Headquarters
Alachua
Employees (FY)
428
Founded
1977
ISIN
US05463X1063
FIGI
BBG000BN46R9
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AXGN is 6.50 USD — it has decreased by 0.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Axogen, Inc. stocks are traded under the ticker AXGN.
Axogen, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
AXGN stock is 4.76% volatile and has beta coefficient of 1.61. Check out the list of the most volatile stocks — is Axogen, Inc. there?
One year price forecast for Axogen, Inc. has a max estimate of 17.00 USD and a min estimate of 11.00 USD.
AXGN earnings for the last quarter are 0.01 USD per share, whereas the estimation was −0.06 USD resulting in a 115.63% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Axogen, Inc. earnings.
Axogen, Inc. revenue for the last quarter amounts to 41.27 M USD despite the estimated figure of 40.45 M USD. In the next quarter revenue is expected to reach 41.25 M USD.
Yes, you can track Axogen, Inc. financials in yearly and quarterly reports right on TradingView.
AXGN stock has fallen by 10.59% compared to the previous week, the month change is a 15.36% fall, over the last year Axogen, Inc. has showed a 35.26% decrease.
AXGN net income for the last quarter is −3.89 M USD, while the quarter before that showed −4.09 M USD of net income which accounts for 4.79% change. Track more Axogen, Inc. financial stats to get the full picture.
Today Axogen, Inc. has the market capitalization of 283.00 M, it has increased by 1.41% over the last week.
No, AXGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AXGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axogen, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 428.00 employees. See our rating of the largest employees — is Axogen, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Axogen, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Axogen, Inc. stock shows the strong sell signal. See more of Axogen, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Axogen, Inc. future price: according to them, AXGN price has a max estimate of 17.00 USD and a min estimate of 11.00 USD. Read a more detailed Axogen, Inc. forecast: see what analysts think of Axogen, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axogen, Inc. EBITDA is −15.91 M USD, and current EBITDA margin is −10.00%. See more stats in Axogen, Inc. financial statements.